We are live on ! Find out more
RNAM

Avidity Biosciences
RNAM

Delisted

RNAM was delisted on the 26th of February, 2026.

Back to rankings

139 hedge funds and large institutions have $1.17B invested in Avidity Biosciences in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 78 increasing their positions, 25 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,483% more call options, than puts

Call options by funds: $2.85M | Put options by funds: $180K

212% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 25

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0.55% less ownership

Funds ownership: 107.76% → 107.21% (-0.55%)

6% less funds holding

Funds holding: 148 → 139 (-9)

26% less capital invested

Capital invested by funds: $1.57B → $1.17B (-$404M)

35% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 23

Holders
139
Holders Change
-9
Holders Change %
-6.08%
% of All Funds
2.22%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
15
Increased
78
Reduced
25
Closed
23
Calls
$2.85M
Puts
$180K
Net Calls
+$2.67M
Net Calls Change
+$5.08M

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$21.2M
2
State Street
State Street
Massachusetts
+$17.8M
3
RI
RTW Investments
New York
+$17.2M
4
Artisan Partners
Artisan Partners
Wisconsin
+$13.3M
5
BBA
Baker Bros. Advisors
New York
+$12.5M

Top Sellers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
-$44.2M
2
Millennium Management
Millennium Management
New York
-$16.7M
3
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$10.2M
4
SCM
Soleus Capital Management
Connecticut
-$6.88M
5
DTC
Deep Track Capital
Connecticut
-$6.66M
Name Holding Trade Value Shares
Change 		Change in
Stake
FFA
126
Farther Finance Advisors
California
$7.89K +$11.3K +514 New
Group One Trading
127
Group One Trading
Illinois
$4.62K +$6.62K +301 New
First Manhattan
128
First Manhattan
New York
$3.07K – – –
TWA
129
TCI Wealth Advisors
Arizona
$2.89K +$4.14K +188 New
BHWM
130
Beaird Harris Wealth Management
Texas
$2.83K – – –
FDCDDQ
131
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2.53K – – –
LC
132
Lindbrook Capital
California
$2.13K -$198 -9 -6%
CSPIA
133
Cary Street Partners Investment Advisory
Virginia
$1.53K – – –
PA
134
Parallel Advisors
California
$1.4K +$1.54K +70 +333%
AF
135
Allworth Financial
California
$614 – – –
SIC
136
Salem Investment Counselors
North Carolina
$538 – – –
S
137
SignatureFD
Georgia
$507 – – –
EI
138
Ellevest Inc
New York
$230 +$330 +15 New
Millennium Management
139
Millennium Management
New York
– -$16.7M -750,445 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
140
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$10.2M -457,500 Closed
SCM
141
Soleus Capital Management
Connecticut
– -$6.88M -310,000 Closed
DTC
142
Deep Track Capital
Connecticut
– -$6.66M -300,000 Closed
CSS
143
Cubist Systematic Strategies
Connecticut
– -$2.86M -129,089 Closed
SCM
144
Silverarc Capital Management
Massachusetts
– -$2.84M -128,000 Closed
PP
145
PDT Partners
New York
– -$1.55M -70,032 Closed
Man Group
146
Man Group
United Kingdom
– -$1.34M -60,200 Closed
NYLIM
147
New York Life Investment Management
New York
– -$682K -30,713 Closed
QT
148
Quantbot Technologies
New York
– -$562K -25,330 Closed
CCM
149
CAAS Capital Management
New York
– -$555K -25,000 Closed
LCM
150
Laurion Capital Management
New York
– -$444K -20,000 Closed
3 4 5
6
7

RNAM Hedge Fund Activity: Q1 2023 in Review

139 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Avidity Biosciences (RNAM) for Q1 2023, worth a combined $1.17B — down 26% from $1.57B a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of RNAM and 15 opened new positions — a net loss of 8 holders — while 25 trimmed existing stakes and 78 added.

The largest buyer was RA Capital Management, adding an estimated $21.2M. The largest seller was Avidity Partners Management, cutting an estimated $44.2M.

  • 139 institutional investors held Avidity Biosciences (RNAM) as of Q1 2023, down from 148 in Q4 2022.
  • Funds reported $1.17B of Avidity Biosciences stock for Q1 2023, down 26% quarter-over-quarter.
  • 15 funds opened new Avidity Biosciences positions in Q1 2023 and 23 closed out, a net change of -8 holders.
  • The largest Avidity Biosciences buyer in Q1 2023 was RA Capital Management, an estimated $21.2M added.
  • The largest Avidity Biosciences seller in Q1 2023 was Avidity Partners Management, an estimated $44.2M sold.

Based on aggregated 13F filings for Q1 2023.